Close

JPMorgan Resumes Allscripts (MDRX) at Underweight

April 29, 2021 6:17 AM EDT Send to a Friend
JPMorgan analyst Anne Samuel resumes coverage on Allscripts (NASDAQ: MDRX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login